Paraquat is excluded by the blood brain barrier in rhesus macaque: An in vivo pet study

Brain Research

Volumn 1259, Issue , 2009, Pages 74-79

  Bartlett, Rachel M ^a   Holden, James E ^a   Nickles, R Jerome ^a   Murali, Dhanabalan ^a   Barbee, David L ^a   Barnhart, Todd E ^a   Christian, Bradley T ^a   DeJesus, Onofre T ^a  

^a University of Wisconsin Health   (United States)

Author keywords

Blood brain barrier; Paraquat; Parkinson's disease; PET imaging; Rhesus macaque

Indexed keywords

CARBON 11; DOPAMINE; PARAQUAT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VOLUME; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; IN VIVO STUDY; LATERAL BRAIN VENTRICLE; MALE; NEUROTOXICITY; NONHUMAN; PINEAL BODY; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CARBON RADIOISOTOPES; IMAGE PROCESSING, COMPUTER-ASSISTED; MACACA MULATTA; MAGNETIC RESONANCE IMAGING; MALE; NEUROTOXINS; PARAQUAT; POSITRON-EMISSION TOMOGRAPHY;

MACACA MULATTA;

EID: 61649113239     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.12.033     Document Type: Article

References (34)

1. Barbeau A., Dallaire L., Buu N.T., Poirier J., and Rucinska E. Comparative behavioral, biochemical and pigmentary effects of MPTP, MPP+ and paraquat in Rana pipiens. Life Sci. 37 (1985) 1529-1538
2. Barlow B.K., Lee D.W., Cory-Slechta D.A., and Opanashuk L.A. Modulation of antioxidant defense systems by the environmental pesticide maneb in dopaminergic cells. Neurotoxicology 26 1 (2005) 63-75
3. Beligaswatte A.M., Kularatne S.A., Seneviratne A.B., Wijenayake M.S., Kularatne W.K., and Pathirage L.M. An outbreak of fatal pneumonitis caused by contamination of illicit alcohol with paraquat. Clin. Toxicol. (Phila) 46 (2008) 768-770
4. Corasaniti M.T., and Nistico G. Determination of paraquat in rat brain by high-performance liquid chromatography. J. Chromatogr. 643 (1993) 419-425
5. Corasaniti M.T., Defilippo R., Rodino P., Nappi G., and Nistico G. Evidence that paraquat is able to cross the blood-brain barrier to a different extent in rats of various age. Funct. Neurology 6 (1991) 385-391
6. Corasaniti M.T., Bagetta G., Rodino P., Gratteri S., and Nistico G. Neurotoxic effects induced by intracerebral and systemic injection of paraquat in rats. Human Exp. Toxicol. 11 (1992) 535-539
7. Corasaniti M.T., Strongoli M.C., Pisanelli A., Bruno P., Rotiroti D., Nappi G., and Nistico G. Distribution of paraquat into the brain after its systemic injection in rats. Funct. Neurology 7 (1992) 51-56
8. Daniel J.W., and Gage J.C. Absorption and excretion of diquat and paraquat in rats. Br. J. Ind. Med. 23 (1966) 133-136
9. Dinis-Oliveira R.J., Duarte J.A., Sanchez-Navarro A., Remiao F., Bastos M.L., and Carvalho F. Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment. Crit. Rev. Toxicol. 38 (2008) 13-71
10. Eichling J.O., Raichle M.E., Grubb Jr. R.L., Larson K.B., and Ter-Pogossian M.M. In vivo determination of cerebral blood volume with radioactive oxygen-15 in the monkey. Circ. Res. 37 (1975) 707-714
11. Fei Q., McCormack A.L., Di Monte D.A., and Ethell D.W. Paraquat neurotoxicity is mediated by a Bak-dependent mechanism. J. Biol. Chem. 283 (2008) 3357-3364
12. Grant H.C., Lantos P.L., and Parkinson C. Cerebral damage in paraquat poisoning. Histopathology 4 (1980) 185-195
13. Hughes J.T. Brain damage due to paraquat poisoning: a fatal case with neuropathological examination of the brain. Neurotoxicology 9 (1988) 243-248
14. Javitch J.A., D, Amato R.J., Strittmatter S.M., and Snyder S.H. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 2173-2177
15. 11C]bisquaternary ammonium compounds. J. Label. Compd. Radiopharm. 45 (2002) 281-289
16. 11C]methyl triflate. Int. J. Rad. Appl. Instrum. [A] 43 (1992) 1383-1385
17. Koller W.C. Paraquat and Parkinson's disease. Neurology 36 (1986) 1147
18. Kuter K., Smialowska M., Wieronska J., Zieba B., Wardas J., Pietraszek M., Nowak P., Biedka I., Roczniak W., Konieczny J., Wolfarth S., and Ossawska K. Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats. Brain Res. 1155 (2007) 196-207
19. Langston J.W., Ballard P., Tetrud J.W., and Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219 (1983) 979-980
20. Lee E.Y., Hwang K.Y., Yang J.O., and Hong S.Y. Predictors of survival after acute paraquat poisoning. Toxicol. Ind. Health 18 (2002) 201-206
21. Li X., Yin J., Cheng C.M., Sun J.L., Li Z., and Wu Y.L. Paraquat induces selective dopaminergic nigrostriatal degeneration in aging C57BL/6 mice. Chin. Med. J. (Engl) 118 (2005) 1357-1361
22. Lindquist N.G., Larsson B.S., and Lyden-Sokolowski A. Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: accumulation in neuromelanin. Neurosci. Lett. 93 (1988) 1-6
23. McCormack A.L., and Di Monte D.A. Effects of l-dopa and other amino acids against paraquat-induced nigrostriatal degeneration. J. Neurochem. 85 (2003) 82-86
24. McCormack A.L., Atienza J.G., Johnston L.C., Andersen J.K., Vu S., and Di Monte D.A. Role of oxidative stress in paraquat-induced dopaminergic cell degeneration. J. Neurochem. 93 (2005) 1030-1037
25. Miller G.W. Paraquat: the red herring of Parkinson's disease research. Toxicol. Sci. 100 (2007) 1-2
26. Murray R.E., and Gibson J.E. Paraquat disposition in rats, guinea pigs and monkeys. Toxicol. Appl. Pharmacol. 27 (1974) 283-291
27. Naylor J., Widdowson P., Simpson M., Farnworth M., Ellis M., and Lock E. Further evidence that the blood/brain barrier impedes paraquat entry into the brain. Human Exp. Toxicol. 14 (1995) 587-594
28. Peng J., Peng L., Stevenson F.F., Doctrow S.R., and Andersen J.K. Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson's disease accelerate age-related neurodegeneration. J. Neurosci. 27 26 (2007) 6914-6922
29. Phelps M.E., Grubb Jr. R.L., and Ter-Pogossian M.M. Correlation between PaCO2 and regional cerebral blood volume by x-ray fluorescence. J. Appl. Physiol. 35 (1973) 274-280
30. Prasad K., Winnik B., Thiruchelvam M.J., Buckley B., Mirochnitchenko O., and Richfield E.K. Prolonged toxicokinetics and toxicodynamics of paraquat in mouse brain. Environ. Health Perspect. 115 (2007) 1448-1453
31. Purisai M.G., McCormack A.L., Cumine S., Li J., Isla M.Z., and Di Monte D.A. Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration. Neurobiol. Dis. 25 (2007) 392-400
32. Rojo A.I., Cavada C., de Sagarra M.R., and Cuadrado A. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats. Exp. Neurol. 208 (2007) 120-126
33. Shimizu K., Ohtaki K., Matsubara K., Aoyama K., Uezono T., Saito O., Suno M., Ogawa K., Hayase N., Kimura K., and Shiono H. Carrier-mediated processes in blood-brain barrier penetration and neural uptake of paraquat. Brain Res. 906 (2001) 135-142
34. Widdowson P.S., Farnworth M.J., Upton R., and Simpson M.G. No changes in behaviour, nigro-striatal system neurochemistry or neuronal cell death following toxic multiple oral paraquat administration to rats. Human Exp. Toxicol. 15 (1996) 583-591